Atlas FDA

CADENCE(R) TIERED THERAPY DEFIBRILLATION SYSTEM

FDA premarket approval P910023/S015 · decided 1997-03-03

Approval details

PMA number
P910023
Supplement
S015
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
CADENCE(R) TIERED THERAPY DEFIBRILLATION SYSTEM
Generic name
Implantable cardioverter defibrillator (non-CRT)
Applicant
ABBOTT MEDICAL
Date received
1996-03-21
Decision date
1997-03-03
Days to decision
347 days
Decision code
APPR
Product code
LWS
Advisory committee
Cardiovascular
Expedited review
No
Location
Sylmar, CA
Statement
APPROVAL FOR VENTRITEX(R) HOUSECALL(TM) SYSTEM WITH TRANSMITTER MODEL TR 2400 (SOFTWARE VERSION 1.1) AND RECEIVER MODEL RE 2400 (SOFTWARE VERSION 1.0)

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EnSite™ X EP System (K262006)Abbott Medical2026-07-15
Amplatzer TorqVue Exchange System (K261631)Abbott Medical2026-06-17
OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001) (K253459)ABBOTT MEDICAL2026-04-24
EnSite™ X EP System (K260212)ABBOTT MEDICAL2026-04-20
Disposable Radiofrequency Cannula (K253907)ABBOTT MEDICAL2026-04-16
Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80 (K260499)ABBOTT MEDICAL2026-03-13
Armada™ 14 NC PTA Catheter (K252512)ABBOTT MEDICAL2026-02-13
Assert-IQ (DM5100) (K253516)ABBOTT MEDICAL2025-12-18